Matches in Nanopublications for { ?s ?p "[The presence of BRAF- and c-kit-activating mutations in malignant melanoma suggests new approaches to treating this disease involving specific tyrosine kinase inhibitors may prove worthwhile and that mutation analysis by high-resolution melting analysis might help guide therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP164707.RAOpMQu1rP_N3bkdk13eKnKsWNk-aRb5ayE0YHVAAJHhM130_assertion description "[The presence of BRAF- and c-kit-activating mutations in malignant melanoma suggests new approaches to treating this disease involving specific tyrosine kinase inhibitors may prove worthwhile and that mutation analysis by high-resolution melting analysis might help guide therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164707.RAOpMQu1rP_N3bkdk13eKnKsWNk-aRb5ayE0YHVAAJHhM130_provenance.
- assertion description "[The presence of BRAF- and c-kit-activating mutations in malignant melanoma suggests new approaches to treating this disease involving specific tyrosine kinase inhibitors may prove worthwhile and that mutation analysis by high-resolution melting analysis might help guide therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP498806.RAMgjJ1ZravshBgxKWJKQHI0hPzxN1VP-DJeGx4CkYWk4130_assertion description "[The presence of BRAF- and c-kit-activating mutations in malignant melanoma suggests new approaches to treating this disease involving specific tyrosine kinase inhibitors may prove worthwhile and that mutation analysis by high-resolution melting analysis might help guide therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498806.RAMgjJ1ZravshBgxKWJKQHI0hPzxN1VP-DJeGx4CkYWk4130_provenance.